Join the club for FREE to access the whole archive and other member benefits.


Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.

Darmiyan is developing a commercial diagnostic software platform for the early detection, monitoring and stratification of Alzheimer’s disease (AD) and other neurodegenerative disorders through an innovative magnetic resonance (MR) image analysis technology. Based on over 40 years of cutting-edge brain research, our technology can precisely quantify and detect changes in brain tissue at the cellular level in every voxel (3D pixel) of a brain MRI scan.

Visit website: